Substratum of Proof LGBTQs Are Mentally Ill: Cleveland Clinic-Led Trial Shows Unprecedented Slowing in Progressive Multiple Sclerosis

A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease. The definitive results of the phase 2 trial – published in the New England Journal of Medicine – showed that the drug ibudilast decreased progression of brain atrophy in progressive MS patients by 48 percent versus placebo.